Changes in the clinical condition of haemodialysis patients.
The characteristics of the dialytic population have substantially changed over the past 30 years, becoming older and with a greater number of coexisting diseases. The considerable evolution in treatment modalities has lead to a significant increase in the efficacy and tolerability of dialysis. However, physicians have to deal with illnesses in long term dialysis survivors that may be a consequence of inadequate renal replacement therapy rather than of the dialysis procedure per se. Cardiovascular diseases are the leading cause of death and, although many of the risk factors are the same as in the general population (i.e. hypertension), some appear to be specific to CRF (i.e. hyperparathyroidism, anaemia). Age is the most important demographic factor associated with increased mortality. The increasing incidence of ESRD diabetic patients, as well as malnutrition, also contribute to higher mortality in RRT. The therapeutic answer to a worsening in clinical condition is adequate medical care (starting in the conservative phase), with particular attention being given to correcting anaemia, hypertension, volume overload and hyperparathyroidism, and preventing malnutrition. Treatment modalities also play a crucial role. Data suggest that adequate dialytic dose (and possibly time) can reduce morbidity and mortality, and on-line sodium and potassium modelling can improve intradialytic cardiovascular stability and reduce arrhythmias. Long-term treatment with synthetic high-flux membranes may confer some beneficial effect on beta2-m amyloidosis-related morbidity and may also reduce mortality. Family and social support greatly affect the quality of life of the patients. However technologically advanced, no procedure can succeed unless it is performed in the context of humanised health care directed towards patient needs.
Locatelli
F
F
Department of Nephrology and Dialysis, Azienda Ospedale di Lecco, Italy. nefrolec@tin.it
Manzoni
C
C
Del Vecchio
L
L
Di Filippo
S
S
D000367:Age Factors; D000740:Anemia / Q000209:etiology; D001672:Biocompatible Materials; D002318:Cardiovascular Diseases / Q000209:etiology; D015897:Comorbidity; D003928:Diabetic Nephropathies / Q000628:therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008567:Membranes, Artificial; D009748:Nutrition Disorders / Q000150:complications; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods; D012307:Risk Factors
D001672:Biocompatible Materials; D008567:Membranes, Artificial